These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 24975340

  • 1. [Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs].
    Kawano H, Suzuki T, Ishii S, Wakahashi K, Kawano Y, Sada A, Minagawa K, Takaya T, Yamashita T, Hirata K, Koriyama K, Nagamatsu Y, Matsui T, Katayama Y.
    Rinsho Ketsueki; 2014 Jun; 55(6):697-702. PubMed ID: 24975340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis.
    Tumaini Massaro J, Chen Y, Ke Z.
    Platelets; 2019 Jun; 30(7):828-835. PubMed ID: 30810479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Development of chronic myelogenous leukemia during treatment with TPO receptor agonist for ITP].
    Hattori H, Kuwayama M, Takamori H, Nishiura N, Karasuno T.
    Rinsho Ketsueki; 2014 Dec; 55(12):2429-32. PubMed ID: 25744045
    [Abstract] [Full Text] [Related]

  • 13. Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists.
    Garabet L, Ghanima W, Hellum M, Sandset PM, Bussel JB, Tran H, Henriksson CE.
    Platelets; 2020 Dec; 31(3):322-328. PubMed ID: 31280643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR.
    Ned Tijdschr Geneeskd; 2007 Nov 24; 151(47):2609-14. PubMed ID: 18161261
    [Abstract] [Full Text] [Related]

  • 17. Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists.
    Rodeghiero F, Ruggeri M.
    Semin Hematol; 2015 Jan 24; 52(1):16-24. PubMed ID: 25578415
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Rodeghiero F, Carli G.
    Ann Hematol; 2017 Sep 24; 96(9):1421-1434. PubMed ID: 28275823
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous Epidural Hematomas due to Cerebral Venous Thrombosis in a Patient with Immune Thrombocytopenic Purpura.
    Ntantos D, Karantali E, Prevezianou A, Angelopoulos P, Bostantjopoulou S.
    J Stroke Cerebrovasc Dis; 2020 Nov 24; 29(11):105244. PubMed ID: 33066947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.